The company is preparing to launch a broader clinical trial for QRX003, which will be conducted by Dr. Amy Paller at Northwestern University. This trial, aimed at gathering further clinical data ...
The study will be conducted by Dr. Amy Paller, of Northwestern University. It is planned that up to eight subjects will be enrolled into the study and will have QRX003 applied twice daily to greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback